Adial Pharmaceuticals Reports Results for Quarter Ended June 30, 2026

What Happened

• Adial Pharmaceuticals, Inc. filed a Current Report on Form 8-K on August 17, 2026 (Item 2.02) and issued a press release that included financial information for the quarter ended June 30, 2026.
• The press release is attached to the 8-K as Exhibit 99.1; the filing also includes the Inline XBRL cover page (Exhibit 104). The 8-K notifies investors of the company’s quarterly results but directs readers to the attached press release for the specific figures.

Key Details

• Filing date: August 17, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Reporting period: Quarter ended June 30, 2026.
• Exhibit attached: 99.1 — press release dated August 17, 2026 (financial information included).
• Inline XBRL cover page included as Exhibit 104.

Why It Matters

• This 8-K provides the company’s latest quarterly performance snapshot (earnings/quarterly results) that can affect investor assessment of revenue, profitability and near-term prospects.
• Retail investors should read the attached press release (Exhibit 99.1) for the specific numbers and compare them with prior quarters and any guidance. Also watch for the company’s upcoming periodic reports (e.g., Form 10-Q) for full financial statements and more detailed disclosures.